Vous avez cherché: napredovalim (Slovène - Anglais)

bolniki s ponavljajočim ali napredovalim malignim gliomom
patients with recurrent or progressive malignant glioma

napredovalim karcinomom ledvičnih celic, vrsto raka ledvic.
advanced renal cell carcinoma, a type of kidney cancer.

neželeni učinki pri bolnikih s ponovljenim ali napredovalim malignim gliomom
adverse reactions in patients with recurrent or progressive malignant glioma

zdravilo firmagon se uporablja za zdravljenje bolnikov z napredovalim rakom prostate.
firmagon is used to treat patients with advanced prostate cancer.

za zdravljenje bolnic z lokalno napredovalim ali metastatskim rakom dojke je priporočeni odmerek
for the treatment of patients with locally advanced or metastatic breast cancer, the recommended dose of docetaxel is 100 mg/m2 in monotherapy.

ta študija je zajela 331 bolnikov z neresektabilnim, lokalno napredovalim ali metastatskim mtc.
this study included 331 patients with unresectable locally advanced or metastatic mtc.

bolniki z napredovalim bazalnoceličnim karcinomom imajo povečano tveganje za razvoj ploščatoceličnega karcinoma kože.
patients with advanced bcc have an increased risk of developing cuscc.

m • skrajšala čas do napredovanja tumorja pri bolnikih z napredovalim rakom glave in vratu,
au in controlled clinical studies, use of nespo and other erythropoiesis-stimulating agents (esas) have shown:

učinkovitost docetaksela v indukcijskem zdravljenju bolnikov z lokalno napredovalim scchn (analiza znamenomzdravljenja)
efficacy of docetaxel in the induction treatment of patients with locally advanced scchn (intent-to- treat analysis)

pri bolnikih z lokalno napredovalim rakom skvamoznih celic glave in vratu se cetuksimab uporablja sočasno z radioterapijo.
in patients with locally advanced squamous cell cancer of the head and neck, cetuximab is used concomitantly with radiation therapy.

učinkovitost docetaksela v indukcijskem zdravljenju bolnikov z lokalno napredovalim scchn (analiza z namenom zdravljenja)
efficacy of docetaxel in the induction treatment of patients with locally advanced scchn (intent-to- treat analysis)

podatki o učinkovitosti zdravljenja bolnikov z ros1-pozitivnim napredovalim nsclc iz Študije 1001 so povzeti v preglednici 7.
efficacy data from ros1-positive advanced nsclc patients from study 1001 are provided in table 7.

pri bolnikih z napredovalim bazalnoceličnim karcinomom, ki so se zdravili z zdravilom erivedge, so poročali o primerih ploščatoceličnega karcinoma kože.
cases of cuscc have been reported in advanced bcc patients treated with erivedge.

preiskovanci (n = 369) z napredovalim sts so bili randomizirani na prejemanje 800 mg pazopaniba na dan ali placeba.
a total of 369 patients with advanced sts were randomised to receive pazopanib 800 mg once daily or placebo.

odraslih z aktivnim in napredovalim psoriatičnim artritisom (boleznijo, ki povzroča nastajanje rdečih, luskastih zaplat na koži in vnetje sklepov);
adults with active and progressive psoriatic arthritis (a disease causing red, scaly patches on the skin and inflammation of the joints);

zdravilo yervoy se uporablja za zdravljenje odraslih z napredovalim melanomom (vrsto kožnega raka, ki prizadene celice, imenovane melanociti).
yervoy is used to treat adults with advanced melanoma (a type of skin cancer affecting cells called melanocytes).

simptomatskim metastatskim bazalnoceličnim karcinomom, z lokalno napredovalim bazalnoceličnim karcinomom, neprimernim za operacijo ali radioterapijo (glejte poglavje 5.1).
ymptomatic metastatic basal cell carcinoma locally advanced basal cell carcinoma inappropriate for surgery or radiotherapy (see section 5.1).

delni odziv je doseglo 32,1 % bolnikov v skupini z metastatskim bazalnoceličnim karcinomom in 35,1 % bolnikov v skupini z lokalno napredovalim bazalnoceličnim karcinomom.
partial response was achieved in 32.1% patients in the mbcc cohort and 35.1% in the labcc cohort.

odraslih bolnikov z napredovalim hipereozinofilnim sindromom (hes) ali kronično eozinofilno levkemijo (cel) s premestitvijo fip1l1- pdgfrα ali obojim.
adult patients with advanced hypereosinophilic syndrome (hes) and/ or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfrα rearrangement.

z napredovalim rakom želodca ali rakom predela, kjer požiralnik (ezofagus) vstopa v želodec (imenovanim adenokarcinom gastro-ezofagealnega prehoda).
advanced gastric cancer (cancer of the stomach) or cancer of the area where the gullet (oesophagus) enters the stomach (known as gastro-oesophageal junction adenocarcinoma).